The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

OncoRes Medical has initiated a clinical trial involving six hospitals in Western Australia and Victoria.

BioPhy announces acquisition by Intrinsic Clinical Systems. The AI-driven platform will continue advancing quality and ...

Thermo Fisher Scientific has entered into a strategic data collaboration with Datavant aimed at expanding real-world data (RWD) interoperability and linkage across clinical research and development ...

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/trial-workflows ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

Over the past decade, a shift has been occurring in biopharma R&D. Despite great advancements in drug technologies and our understanding of diseases, it is getting harder to develop new drugs and ...

Clinical and translational research members, such as faculty, physicians, clinicians, coordinators, administrators and research ...

Montreal and Québec City Friday, February 13, 2026, 17:00 Hrs [IST] ...

Advances in our understanding of cancer biology have led to the discovery of a spectrum of new therapeutic targets. However, despite remarkable progress in the identification and characterization of ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...